Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Deniz Karasoy"'
Autor:
Morten Lamberts, Deniz Karasoy, Nikolai Juul, Christine Benn Christiansen, Morten Lock Hansen, Christian Torp-Pedersen, Rikke Sørensen, Jonas Bjerring Olesen, Gunnar Gislason
Publikováno v:
Juul, N, Gislason, G, Olesen, J B, Lamberts, M, Hansen, M L, Karasoy, D, Christiansen, C B, Torp-Pedersen, C & Sorensen, R 2017, ' Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups ', European Heart Journal: Acute Cardiovascular Care, vol. 6, no. 6, pp. 511-521 . https://doi.org/10.1177/2048872614538848
Juul, N, Gislason, G, Olesen, J B, Lamberts, M, Hansen, M L, Karasoy, D, Christiansen, C B, Torp-Pedersen, C & Sorensen, R 2017, ' Risk and benefit of dual antiplatelet treatment among nonrevascularized myocardial infarction patients in different age groups ', European Heart Journal: Acute Cardiovascular Care, vol. 6, no. 6, pp. 511-521 . https://doi.org/10.1177/2048872614538848
Juul, N, Gislason, G, Olesen, J B, Lamberts, M, Hansen, M L, Karasoy, D, Christiansen, C B, Torp-Pedersen, C & Sorensen, R 2017, ' Risk and benefit of dual antiplatelet treatment among nonrevascularized myocardial infarction patients in different age groups ', European Heart Journal: Acute Cardiovascular Care, vol. 6, no. 6, pp. 511-521 . https://doi.org/10.1177/2048872614538848
BACKGROUND: Dual anti-platelet treatment with clopidogrel and aspirin is indicated for most patients after myocardial infarction. We examined the risk/benefit relationship of dual anti-platelet treatment according to age in a nationwide cohort of 30,
Autor:
Anders P. Mikkelsen, Morten Hvidtfeldt, Morten Lamberts, Jonas Bjerring Olesen, Søren Paaske Johnsen, Christian Torp-Pedersen, Gunnar Gislason, Morten Lock Hansen, Steen Husted, Axel Brandes, Deniz Karasoy
Publikováno v:
Mikkelsen, A P, Hansen, M L, Olesen, J B, Hvidtfeldt, M W, Karasoy, D, Husted, S, Johnsen, S P, Brandes, A, Gislason, G, Torp-Pedersen, C & Lamberts, M 2016, ' Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings ', Europace, vol. 18, no. 4, pp. 492-500 . https://doi.org/10.1093/europace/euv242
AIMS: Patients with atrial fibrillation (AF) are encountered and treated in different healthcare settings, which may affect the quality of care. We investigated the use of oral anticoagulant (OAC) therapy and the risk of thrombo-embolism (TE) and ble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1103ef1e35898f342805c9579522ec30
https://vbn.aau.dk/da/publications/17310c2c-90b6-4c87-a8c0-1c367d5eccdf
https://vbn.aau.dk/da/publications/17310c2c-90b6-4c87-a8c0-1c367d5eccdf
Autor:
Gunnar Gislason, Morten Lock Hansen, Christian Torp-Pedersen, Lars Køber, Jonas Bjerring Olesen, Carolina Malta Hansen, Deniz Karasoy, Morten Lamberts, Søren Lund Kristensen, Martin H. Ruwald
Publikováno v:
Circulation. 126:1185-1193
Background— Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleed
Publikováno v:
Volume: 41, Issue: 3 495-501
Dicle Tıp Dergisi
Dicle Medical Journal, Vol 41, Iss 3, Pp 495-501 (2014)
Dicle Tıp Dergisi
Dicle Medical Journal, Vol 41, Iss 3, Pp 495-501 (2014)
Objective: In this study, it was aimed to evaluate demographic and laboratory characteristics of the patients with upper gastrointestinal system (GIS) bleeding define the factors leading to bleeding. Methods: The study included 285 patients aged betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83778e7117b1ff0c4c21b0f747c8a07
https://dergipark.org.tr/tr/pub/dicletip/issue/4685/63792
https://dergipark.org.tr/tr/pub/dicletip/issue/4685/63792
Autor:
Deniz Karasoy, Morten Hvidtfeldt, Arne Johannessen, Gunnar Gislason, Christian Torp-Pedersen, Jim Hansen, Lars Køber, Morten Lock Hansen, Cengiz Özcan
Publikováno v:
Karasoy, D, Gislason, G H, Hansen, J, Johannessen, A, Køber, L, Hvidtfeldt, M, Özcan, C, Torp-Pedersen, C & Hansen, M L 2015, ' Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding : long-term follow-up in nationwide cohort of Denmark ', European Heart Journal, vol. 36, no. 5, pp. 307-314 . https://doi.org/10.1093/eurheartj/ehu421
Karasoy, D, Gislason, G H, Hansen, J, Johannessen, A, Køber, L, Hvidtfeldt, M, Ozcan, C, Torp-Pedersen, C & Hansen, M L 2015, ' Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding : Long-term follow-up in nationwide cohort of Denmark ', European Heart Journal, vol. 36, no. 5, pp. 307-315 . https://doi.org/10.1093/eurheartj/ehu421
Karasoy, D, Gislason, G H, Hansen, J, Johannessen, A, Køber, L, Hvidtfeldt, M, Ozcan, C, Torp-Pedersen, C & Hansen, M L 2015, ' Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding : Long-term follow-up in nationwide cohort of Denmark ', European Heart Journal, vol. 36, no. 5, pp. 307-315 . https://doi.org/10.1093/eurheartj/ehu421
AIM: To investigate the long-term risk of thromboembolism and serious bleeding associated with oral anticoagulation (OAC) therapy beyond 3 months after radiofrequency ablation (RFA) of atrial fibrillation (AF).METHODS AND RESULTS: Linking Danish admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9536da6850d5974796f9bfa12eb88d
https://vbn.aau.dk/da/publications/e419dcb1-0847-4733-a226-59866a308319
https://vbn.aau.dk/da/publications/e419dcb1-0847-4733-a226-59866a308319
Autor:
Lars Køber, Gunnar Gislason, Rikke Malene H.G. Jepsen, Jonas Bjerring Olesen, Morten Lock Hansen, Martin H. Ruwald, Steen Elkjær Husted, Deniz Karasoy, Christian Torp-Pedersen, Jim Hansen
Publikováno v:
Hansen, M L, Jepsen, R M H G, Olesen, J B, Ruwald, M H, Karasoy, D, Gislason, G H, Hansen, J, Køber, L, Husted, S & Torp-Pedersen, C 2015, ' Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy ', Europace, vol. 17, no. 1, pp. 18-23 . https://doi.org/10.1093/europace/euu189
Aims To study the risk of thromboembolism in a nationwide cohort of atrial fibrillation patients undergoing direct current (DC) cardioversion with or without oral anticoagulant coverage. Methods and results A retrospective study of 16 274 patients in
Autor:
Salih Baser, Meryem İlkay Eren Karanis, Kemal Kalkan, Samil Ecirli, Husniye Baser, Baris Ayhan, Deniz Karasoy
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Vaccine. 28:2158-2160
A patient admitted to hospital for a supraclavicular painful mass. Ultrasonography showed soliter lymphadenopathy. He underwent H1N1 vaccination 1 week before this lymphadenopathy developed. Groosly the mass measured 1cmx0.8cmx0.8cm. It was round, ye
Autor:
Gunnar Gislason, Morten Lock Hansen, Jonas Bjerring Olesen, Christian Torp-Pedersen, Deniz Karasoy, Jim Hansen, Arne Johannessen
Publikováno v:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 15(5)
Aims Trends in patient selection and pharmacotherapy before radiofrequency ablation (RFA) of atrial fibrillation are not well studied. We examined temporal trends in RFA utilization on a nationwide scale in Denmark. Methods and results Using the cros
Autor:
Martin H. Ruwald, Jonas Bjerring Olesen, Lars Køber, Morten Lamberts, Jesper Lindhardsen, Gunnar Gislason, Anne-Marie Schjerning Olsen, Deniz Karasoy, Christian Torp-Pedersen, Morten Hartvig Hansen
Publikováno v:
Journal of the American College of Cardiology. 59(13)